Chengdu Yuandong Biofawei This anti-dementia drug first imitation will be taken down

Medicine Network October 29th, recently, the official website of the State Drug Administration shows that Chengdu Yuandong Bio to imitate the 3 categories of reported hydrochloric acid methionine slow release capsule into the administrative approval stage, is expected to take the first imitation.
In addition to the hydrochloric acid methion slow release capsule, Chengdu Yuandong Bio's Kapeta bin tablets, Glon ammonium bromide injection registration status has also been changed to "in the approval", the company will usher in a new intensive harvest period.
HYDRO is a new, low-moderate affinity, voltage dependence, non-competitive N-methyl-D-tiandongine (NMDA) sensor antagonist, non-competitive blocking of NMDA subjects, reduce glutamate-induced NMDA subjectivity overexcitement, prevent apoptosis, improve memory, is a new generation of drugs to improve cognitive function. according to
meters of intranet data, in 2019, China's urban public hospitals, county-level public hospitals, urban community centers and township hospitals (China's public medical institutions) terminal sales of more than 500 million yuan, an increase of 16.41 percent year-on-year.
the current domestic market of the United States King Kong products only hydrochloric acid gold tablets and hydrochloric acid gold kong oral solution, hydrochloric acid gold medallion release capsules have not yet been approved for production.
Hydrochloric acid Meigang slow release capsule new classification report production source: Mi Net consistent evaluation database Mi Net data show that Chengdu Yuandong Bio, Qingdao Baiyang Pharmaceuticals, Zhejiang Jingxin Pharmaceuticals, Yichang People's Fu Pharmaceuticals ... 8 enterprises to copy 3 categories of submitted hydrochloric acid mei-King Kong slow release capsule listing application, Chengdu Yuandong biological product registration status has been changed to "in the approval", is expected to take the lead in the first imitation.
Chengdu Yuandong Bio in the approval of product source: Mi Net MED2.0 China Drug Review Database is worth mentioning that Chengdu Yuandong Bio will usher in a new intensive harvest period.
in addition to the hydrochloric acid methion slow release capsules, the listing status of capedabin tablets and Glon ammonium bromide injections was changed to "in-approval" on October 26 and October 14, respectively.
, the Glon ammonium bromide injection of Chengdu Yuandong Bio is expected to become the second domestic, and caperta bin tablets are expected to become the fourth domestic.
source: MiNet Database, NMPA